| 1 |
Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment |
用于监测接受二线奥希替尼治疗的NSCLC患者的综合液体活检分析 |
October 2024 |
| 2 |
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer |
局部中/高危和转移性前列腺癌中循环肿瘤细胞的多标记分析 |
October 2024 |
| 3 |
Low pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple negative breast cancer |
循环肿瘤细胞的低覆盖全基因组测序以评估三阴性乳腺癌的染色体不稳定性 |
September 2024 |
| 4 |
Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations |
通过免疫荧光和细胞病理学评估识别转移性乳腺癌患者外周血中由FDA批准的Parsortix® PC1系统捕获的循环肿瘤细胞 |
August 2024 |
| 5 |
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer |
肺癌中循环肿瘤细胞分离和计数技术的比较研究 |
August 2024 |
| 6 |
Combined microfluidic enrichment and staining workflow for single-cell analysis of circulating tumor cells in metastatic prostate cancer patients |
转移性前列腺癌患者循环肿瘤细胞的单细胞分析微流控富集与染色工作流程 |
July 2024 |
| 7 |
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma |
单一循环肿瘤细胞的突变分析显示黑色素瘤的肿瘤内异质性 |
June 2024 |
| 8 |
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium |
外周血基因表达标志物与铂耐药卵巢癌患者结局的研究：欧洲GANNET53联盟的研究 |
March 2024 |
| 9 |
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation |
循环肿瘤细胞及其相关转录物在小细胞肺癌中的预后意义：向临床应用迈出一步 |
January 2024 |
| 10 |
Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix System |
循环肿瘤细胞和循环肿瘤DNA的分子特征分析：利用Parsortix系统从单一血液样本中获取互补见解 |
January 2024 |
| 11 |
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy |
纤溶酶原激活物抑制剂1与高级别浆液性卵巢癌的转移相关，并在接受新辅助化疗的患者中减少 |
December 2023 |
| 12 |
Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis |
靶向翻译和细胞周期反向影响CTC代谢，但不影响转移 |
November 2023 |
| 13 |
DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts |
DanioCTC：在斑马鱼异种移植模型中分析转移性乳腺癌患者的循环肿瘤细胞 |
November 2023 |
| 14 |
Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping |
在头颈部鳞状细胞癌中采用质谱流式技术进行循环肿瘤细胞蛋白组学表征以实现深度表型分析的可行性 |
October 2023 |
| 15 |
Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients |
从乳腺癌患者骨髓中分离转移性肿瘤细胞的微流控方法 |
September 2023 |
| 16 |
Analytical performance of the FDA-cleared Parsortix® PC1 system |
FDA批准的Parsortix® PC1系统的分析性能 |
August 2023 |
| 17 |
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer |
奥拉帕利单用或联合顺铂或Durvalumab治疗可切除头颈癌的II期窗口研究 |
August 2023 |
| 18 |
Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status |
分离和表征胶质母细胞瘤循环肿瘤细胞的创新方法及其与肿瘤突变状态的相关性 |
June 2023 |
| 19 |
Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C ProMeta 1) |
评估局部前列腺癌患者循环肿瘤细胞状态以预测根治性前列腺切除术治疗失败的前瞻性研究方案（C ProMeta 1） |
June 2023 |
| 20 |
Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer |
循环肿瘤细胞、巨核细胞和高免疫炎症环境在转移性乳腺癌中的相关性 |
June 2023 |
| 21 |
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer |
循环肿瘤细胞的转录组分析以预测转移性去势抵抗性前列腺癌的临床结果 |
May 2023 |
| 22 |
Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patients |
在非小细胞肺癌患者中比较细胞学印迹、循环肿瘤细胞和肿瘤组织的PD-L1表达 |
March 2023 |
| 23 |
Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer |
循环肿瘤细胞和血浆cfDNA的术前突变分析为早期非小细胞肺癌复发的早期预测提供互补信息：一项初步研究 |
March 2023 |
| 24 |
The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients |
桥粒蛋白desmocollin 2在三阴性乳腺癌患者肿瘤进展中的作用 |
March 2023 |
| 25 |
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer |
利用循环肿瘤细胞及其基因表达预测转移性前列腺癌中多西他赛疗效的潜力 |
January 2023 |
| 26 |
Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma |
循环癌相关巨噬细胞样细胞作为胰腺导管腺癌潜在的新预后标志物 |
November 2022 |
| 27 |
Effect of short-term storage of blood samples on gene expression in lung cancer patients |
短期存储血液样本对肺癌患者基因表达的影响 |
November 2022 |
| 28 |
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix®PC1 System |
使用Parsortix®PC1系统收集和表征转移性乳腺癌患者循环肿瘤细胞的多中心临床研究 |
October 2022 |
| 29 |
Comparison of microfuidic platforms for the enrichment of circulating tumor cells in breast cancer patients |
乳腺癌患者循环肿瘤细胞富集微流控平台的比较 |
September 2022 |
| 30 |
Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma |
表征头颈部鳞状细胞癌中循环肿瘤细胞的上皮-间质转化状态 |
July 2022 |
| 31 |
Powering single cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients |
推动单细胞基因组学以解析非小细胞肺癌患者中循环肿瘤细胞亚群 |
July 2022 |
| 32 |
Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions |
使用微孔玻片检测和分离复杂细胞悬液中的单个循环肿瘤细胞 |
June 2022 |
| 33 |
Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung Cancer |
早期非小细胞肺癌患者循环肿瘤细胞的代谢相关基因表达 |
June 2022 |
| 34 |
The metastatic spread of breast cancer accelerates during sleep |
乳腺癌的转移扩散在睡眠期间加速 |
June 2022 |
| 35 |
DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection |
早期非小细胞肺癌液体活检成分中肿瘤抑制基因的DNA甲基化分析：一种有前景的早期检测工具 |
May 2022 |
| 36 |
Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer |
小细胞肺癌循环肿瘤细胞上PD-L1表达的评估 |
May 2022 |
| 37 |
Invadopodia play a role in prostate cancer progression |
侵袭足在前列腺癌进展中发挥作用 |
April 2022 |
| 38 |
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma |
从肺癌和肉瘤患者冷冻保存的外周血单个核细胞中分离的循环肿瘤细胞的单细胞表型和分子特征分析 |
March 2022 |
| 39 |
An in vivo CRISPR screen identifies stepwise genetic dependencies of metastatic progression |
体内CRISPR筛选识别转移进展的逐步遗传依赖性 |
February 2022 |
| 40 |
Microtubule disruption reduces metastasis more effectively than primary tumor growth |
微管破坏比减少原发性肿瘤生长更有效地降低转移 |
February 2022 |
| 41 |
Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy |
环氧合酶2效应基因作为液体活检检测结直肠癌循环肿瘤细胞的潜在炎症相关生物标志物 |
January 2022 |
| 42 |
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early stage triple negative breast cancer |
早期三阴性乳腺癌患者的原发性肿瘤组织和循环肿瘤细胞的拷贝数变异分析 |
January 2022 |
| 43 |
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer |
循环肿瘤细胞转录组学作为转移性乳腺癌中的活检替代物 |
January 2022 |
| 44 |
Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients |
卵巢癌患者循环肿瘤细胞上的多标记免疫荧光染色和PD-L1检测 |
December 2021 |
| 45 |
DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment |
NSCLC患者在奥希替尼治疗前后血浆游离DNA和配对CTC中的DNA甲基化分析 |
November 2021 |
| 46 |
Cancer Stem Cell-like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer |
干细胞样循环肿瘤细胞在非小细胞肺癌中的预后意义 |
November 2021 |
| 47 |
Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery |
即时样本固定增加头颈部鳞状细胞癌中循环肿瘤细胞（CTC）的捕获并保持其表型：迈向微流控CTC生物标志物发现的标准化方法 |
November 2021 |
| 48 |
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small cell lung cancer treated with pembrolizumab |
接受帕博利珠单抗治疗的转移性非小细胞肺癌患者中循环游离DNA和循环肿瘤细胞的临床潜力 |
August 2021 |
| 49 |
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer |
在转移性前列腺癌中验证无细胞RNA和循环肿瘤细胞的分子标志物分析 |
August 2021 |
| 50 |
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms |
神经内分泌肿瘤中单个循环肿瘤细胞的全基因组测序 |
July 2021 |
| 51 |
Morphological features of breast cancer circulating tumor cells in blood after physical and biological type of isolation |
乳腺癌循环肿瘤细胞在物理和生物分离后的血液中形态特征 |
July 2021 |
| 52 |
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis |
在脑转移癌症患者中CTC上的CD74和CD44表达 |
June 2021 |
| 53 |
Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR |
使用Crystal Digital PCR检测NSCLC患者在奥希替尼治疗前后血浆cfDNA和配对CTC中的EGFR突变 |
May 2021 |
| 54 |
A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients |
一种基于微流控的过滤系统，用于从乳腺癌患者中富集骨髓扩散性肿瘤细胞 |
May 2021 |
| 55 |
Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma |
评估一种标志物非依赖的循环肿瘤细胞分离方法在食管腺癌中的应用 |
May 2021 |
| 56 |
Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer |
单羧酸转运蛋白4（MCT4）在早期非小细胞肺癌患者循环肿瘤细胞中的表达及其预后意义 |
April 2021 |
| 57 |
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy |
新辅助化疗治疗的三阴性乳腺癌患者的血液基因组学研究 |
March 2021 |
| 58 |
Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells |
富含半胱氨酸的血管生成诱导因子61：作为扩散性乳腺癌细胞的促生存功能和生物标志物的作用 |
February 2021 |
| 59 |
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD L1 during osimertinib treatment in NSCLC patients |
循环肿瘤细胞中的基因表达揭示了在NSCLC患者奥希替尼治疗期间EMT和PD L1的动态作用 |
January 2021 |
| 60 |
Proficiency testing to assess technical performance for CTC-processing and detection methods in CANCER-ID |
用于评估CANCER-ID中CTC处理和检测方法技术性能的能力验证测试 |
January 2021 |
| 61 |
EMT independent detection of circulating tumor cells in human blood samples and pre clinical mouse models of metastasis |
在人类血液样本和转移的临床前小鼠模型中检测EMT非依赖性循环肿瘤细胞 |
January 2021 |
| 62 |
Antigen-agnostic microfluidics based circulating tumor cell enrichment and downstream molecular characterization |
基于抗原不可知微流控的循环肿瘤细胞富集及下游分子特征分析 |
October 2020 |
| 63 |
Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells |
低氧触发聚集循环肿瘤细胞的内渗 |
September 2020 |
| 64 |
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer |
乳腺癌中循环肿瘤细胞与单一转移性活检之间外显子组测序可行性试点研究 |
July 2020 |
| 65 |
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy |
优化非小细胞肺癌患者抗PD-1免疫治疗中循环肿瘤细胞的富集以进行下游表型分析 |
June 2020 |
| 66 |
Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma |
在头颈部鳞状细胞癌中直接比较基于大小与EpCAM依赖性CTC富集在基因表达和DNA甲基化水平上的差异 |
April 2020 |
| 67 |
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients |
使用游离DNA和癌症患者的循环肿瘤细胞检测MET改变 |
February 2020 |
| 68 |
Cancer transcriptomic profiling from rapidly enriched circulating tumor cells |
从快速富集的循环肿瘤细胞中进行癌症转录组分析 |
February 2020 |
| 69 |
ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium |
ALCAM通过与血管内皮的相互作用促进非小细胞肺癌脑转移的形成 |
February 2020 |
| 70 |
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression |
肾细胞癌中单个循环肿瘤细胞的分析揭示了与进展相关的表型异质性和基因组改变 |
February 2020 |
| 71 |
Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients |
癌症患者中标签非依赖性富集和自动检测循环肿瘤细胞的预分析和分析变量 |
February 2020 |
| 72 |
Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells |
黑色素瘤循环肿瘤细胞异质性群体的检测及其预后作用 |
February 2020 |
| 73 |
Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients |
黑色素瘤患者血液中循环肿瘤细胞和循环肿瘤DNA的患者内异质性 |
October 2019 |
| 74 |
Non-invasive detection of clinically significant prostate cancer using circulating tumor cells |
使用循环肿瘤细胞无创检测临床显著性前列腺癌 |
September 2019 |
| 75 |
Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects |
头颈癌中的循环肿瘤细胞生物标志物：当前进展与未来前景 |
August 2019 |
| 76 |
Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer |
小细胞肺癌患者中通过微流控平台富集的循环肿瘤细胞的分子特征 |
August 2019 |
| 77 |
Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance |
诊断性单采术支持单个循环肿瘤细胞可靠的转录组分析，以表征内分泌耐药性方面的细胞间异质性 |
June 2019 |
| 78 |
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors |
NSCLC患者循环肿瘤细胞中PD-L1表达的检测及其与PD-1/PD-L1抑制剂反应的相关性 |
June 2019 |
| 79 |
PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling |
PMN-MDSCs通过ROS/Notch/Nodal信号通路的相互作用增强CTC的转移特性 |
April 2019 |
| 80 |
Assessing metastatic potential of breast cancer cells based on EGFR dynamics |
基于EGFR动态评估乳腺癌细胞的转移潜能 |
March 2019 |
| 81 |
Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products |
从诊断性单采产品中进行无标签富集和活性循环肿瘤细胞的分子特征分析 |
February 2019 |
| 82 |
Neutrophils escort circulating tumour cells to enable cell cycle progression |
中性粒细胞护送循环肿瘤细胞以促进细胞周期进展 |
February 2019 |
| 83 |
Microfluidic enrichment, isolation and characterization of disseminated melanoma cells from lymph node samples |
从淋巴结样本中通过微流控技术富集、分离和表征扩散性黑色素瘤细胞 |
January 2019 |
| 84 |
Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding |
循环肿瘤细胞聚集改变DNA甲基化以促进转移播种 |
January 2019 |
| 85 |
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer |
地诺单抗治疗与乳腺癌患者中循环肿瘤细胞的消失相关 |
November 2018 |
| 86 |
Detection of circulating tumour cell clusters in human glioblastoma |
检测人类胶质母细胞瘤中的循环肿瘤细胞簇 |
August 2018 |
| 87 |
The Parsortix® Cell Separation System – A Versatile Liquid Biopsy Platform |
Parsortix®细胞分离系统：多功能液体活检平台 |
July 2018 |
| 88 |
The precious cell block |
珍贵的细胞块 |
March 2018 |
| 89 |
Challenges in using liquid biopsies for gene expression profiling |
使用液体活检进行基因表达分析的挑战 |
January 2018 |
| 90 |
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells |
循环肿瘤细胞中AR-V7、AR-FL、PSA和KRAS点突变的原位检测和定量 |
January 2018 |
| 91 |
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells |
通过新型微流控平台有效去除白细胞，实现循环肿瘤细胞的分子检测和特征分析 |
November 2017 |
| 92 |
Comparison of isolation platforms for detection of circulating renal cell carcinoma cells |
循环肾细胞癌细胞检测的分离平台比较 |
September 2017 |
| 93 |
A novel workflow to enrich and isolate patient-matched EpCAM high and EpCAM low/negative CTCs enables the comparative characterization of the PIK3CA status in metastatic breast cancer |
一种新的工作流程富集和分离与患者匹配的EpCAM高表达和EpCAM低/阴性CTCs，用于转移性乳腺癌中PIK3CA状态的比较表征 |
August 2017 |
| 94 |
The novel association of circulating tumor cells and circulating megakaryocytes with prostate cancer prognosis |
循环肿瘤细胞和循环巨核细胞与前列腺癌预后的新型关联 |
June 2017 |
| 95 |
Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells |
通过单个循环肿瘤细胞的多重转录组分析评估肿瘤异质性 |
September 2016 |
| 96 |
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells |
一种基于大小和变形性分离并随后进行活性循环肿瘤细胞分子特征分析的新型微流控平台 |
January 2016 |
| 97 |
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumor cells in patients with small cell lung cancer |
一种新型微流控设备的临床评价：用于小细胞肺癌患者循环肿瘤细胞的表位非依赖性富集 |
November 2015 |
| 98 |
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System |
一种新型基于大小的循环肿瘤细胞分离系统的优化和评估 |
September 2015 |